Edward Margolin, MD
Toronto, Ontario, M5G 1X5, Canada
NCT Number: NCT01426672
PURPOSE:
The purpose of this study is to quantitatively assess the efficacy of monovision correction in the treatment of acquired small angle binocular diplopia in adult patients.
METHOD:
Twenty patients with symptomatic diplopia were enrolled in a prospective treatment trial. All had stable deviations of 10 prism diopters or less for over three months. Each received monovision spectacles and/ or contact lenses with distance correction in the dominant eye. Half received a +3.00 diopter (D) add and the others received +2.50 D. The validated and standardized Diplopia Questionnaire and Amblyopia and Strabismus Questionnaire (ASQE) were used to quantify the efficacy of monovision correction for diplopia by measuring the functional impact on vision-specific quality of life.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 1
Toronto, Ontario, M5G 1X5, Canada
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 2 years
To determine whether monovision correction was useful for the correction of small angle deviations in strabismic patients
Mount Sinai Hospital, Canada
Other
Monovision for Treatment of Diplopia
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07180394
Cranial Nerve Diseases, Esotropia
Rawalpindi, Punjab Province, Pakistan
View Trial Details